Benefits and risks of clopidogrel vs. aspirin monotherapy after recent ischemic stroke: a systematic review and meta‐analysis
M Paciaroni, B Ince, B Hu, JS Jeng… - Cardiovascular …, 2019 - Wiley Online Library
Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …
[HTML][HTML] Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis
Y Yang, Z Huang, X Zhang - Medicine, 2021 - journals.lww.com
Objective: Patients experiencing acute ischemic stroke or transient ischemic attack are
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …
Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
M Lee, YL Wu, JL Saver, HC Lee, JD Lee, KC Chang… - Bmj Open, 2014 - bmjopen.bmj.com
Objective There is insufficient evidence on which to base a recommendation for optimal
antiplatelet therapy following a stroke while on aspirin. The objective was to compare …
antiplatelet therapy following a stroke while on aspirin. The objective was to compare …
Antiplatelet therapy after noncardioembolic stroke: an individual patient data network meta-analysis
Background and Purpose—We assessed the efficacy and safety of antiplatelet agents after
noncardioembolic stroke or transient ischemic attack and examined how these vary …
noncardioembolic stroke or transient ischemic attack and examined how these vary …
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials
Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …
Comparison between aspirin and clopidogrel in secondary stroke prevention based on real‐world data
Background Clopidogrel was thought to be superior to aspirin for secondary prevention of
vascular diseases in clinical trials. In this study we assessed the safety and efficacy of …
vascular diseases in clinical trials. In this study we assessed the safety and efficacy of …
Treatment effect of clopidogrel plus aspirin within 12 hours of acute minor stroke or transient ischemic attack
Background The aim of this study was to analyze the benefits and safety associated with the
combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic …
combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic …
Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone
KS Hong, SH Lee, EG Kim, KH Cho, DI Chang, JH Rha… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—In patients with acute ischemic stroke caused by large artery
atherosclerosis, clopidogrel plus aspirin versus aspirin alone might be more effective to …
atherosclerosis, clopidogrel plus aspirin versus aspirin alone might be more effective to …
Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA
SC Johnston, JD Easton, M Farrant… - … England Journal of …, 2018 - Mass Medical Soc
Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …
Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke: a secondary analysis from the POINT …
SC Johnston, JJ Elm, JD Easton, M Farrant… - Circulation, 2019 - Am Heart Assoc
Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …